Novel Therapy for Age-related Macular Degeneration

Maculaser project develops novel medical technology for treatment of common eye-disease, AMD, whose treatment constitutes a major unmet need: It is the leading cause of blindness in the developed world, with total direct healthcare system cost of 200 billion euros annually.

Our innovations allow clinicians to perform previously infeasible laser therapy and help millions of people to retain their vision.